SCIORTINO, Giuseppe
 Distribuzione geografica
Continente #
NA - Nord America 1.206
AS - Asia 641
SA - Sud America 504
EU - Europa 226
AF - Africa 35
Totale 2.612
Nazione #
US - Stati Uniti d'America 1.155
BR - Brasile 453
SG - Singapore 307
CN - Cina 120
HK - Hong Kong 67
FI - Finlandia 57
UA - Ucraina 42
VN - Vietnam 32
DE - Germania 30
IT - Italia 27
TR - Turchia 23
AR - Argentina 22
MX - Messico 21
CA - Canada 19
IQ - Iraq 15
ZA - Sudafrica 15
IN - India 13
BD - Bangladesh 12
PL - Polonia 12
SE - Svezia 11
GB - Regno Unito 10
EC - Ecuador 9
KR - Corea 9
NL - Olanda 9
JP - Giappone 8
ID - Indonesia 7
ES - Italia 6
JO - Giordania 6
MA - Marocco 6
UZ - Uzbekistan 6
VE - Venezuela 6
CO - Colombia 5
RU - Federazione Russa 5
HN - Honduras 4
AE - Emirati Arabi Uniti 3
AT - Austria 3
BE - Belgio 3
CL - Cile 3
FR - Francia 3
KE - Kenya 3
AO - Angola 2
AZ - Azerbaigian 2
DO - Repubblica Dominicana 2
IE - Irlanda 2
JM - Giamaica 2
NP - Nepal 2
PA - Panama 2
PE - Perù 2
PK - Pakistan 2
PY - Paraguay 2
SA - Arabia Saudita 2
SN - Senegal 2
TN - Tunisia 2
AL - Albania 1
CG - Congo 1
DZ - Algeria 1
GA - Gabon 1
GE - Georgia 1
GF - Guiana Francese 1
HU - Ungheria 1
LT - Lituania 1
MD - Moldavia 1
MN - Mongolia 1
OM - Oman 1
PH - Filippine 1
QA - Qatar 1
RO - Romania 1
RS - Serbia 1
TT - Trinidad e Tobago 1
TZ - Tanzania 1
UY - Uruguay 1
YT - Mayotte 1
Totale 2.612
Città #
Dallas 453
Chandler 209
Singapore 161
Hong Kong 67
Ashburn 54
Beijing 52
Princeton 38
Helsinki 34
São Paulo 29
Shanghai 22
Los Angeles 17
Mountain View 15
New York 15
Wilmington 14
Falkenstein 13
Rio de Janeiro 13
Santa Clara 13
Council Bluffs 12
The Dalles 12
Belo Horizonte 10
Columbus 10
Hanoi 10
Ho Chi Minh City 10
Warsaw 10
Brasília 9
Espoo 9
Seoul 9
Tokyo 8
Denver 7
Lappeenranta 7
Querétaro 7
Salvador 7
Toronto 7
Amman 6
Jakarta 6
Johannesburg 6
Montreal 6
Porto Alegre 6
San Francisco 6
Turku 6
Atlanta 5
Baghdad 5
Boardman 5
Campinas 5
Cape Town 5
Curitiba 5
Phoenix 5
Quartucciu 5
Recife 5
Santo André 5
Stockholm 5
Tashkent 5
Amsterdam 4
Ankara 4
Diadema 4
Florianópolis 4
Guarulhos 4
Istanbul 4
Maringá 4
Mexico City 4
Munich 4
Sorocaba 4
Sumaré 4
Ann Arbor 3
Barbianello 3
Brussels 3
Campo Grande 3
Chicago 3
Erbil 3
Frankfurt am Main 3
Guayaquil 3
Jacksonville 3
Kilis 3
London 3
Manaus 3
Marília 3
Mauá 3
Montes Claros 3
Nairobi 3
Nanchang 3
Nuremberg 3
Orem 3
Osasco 3
Ottawa 3
Poplar 3
Quito 3
Ribeirão Preto 3
Rome 3
São Bernardo do Campo 3
São Gonçalo 3
São José dos Campos 3
Volta Redonda 3
Americana 2
Angra dos Reis 2
Antakya 2
Aracaju 2
Asunción 2
Baku 2
Bariri 2
Barueri 2
Totale 1.612
Nome #
Covalent and non-covalent binding in vanadium–protein adducts 118
Chemistry of mixed-ligand oxidovanadium(IV) complexes of aroylhydrazones incorporating quinoline derivatives: Study of solution behavior, theoretical evaluation and protein/DNA interaction 115
DFT Protocol for EPR Prediction of Paramagnetic Cu(II) Complexes and Application to Protein Binding Sites 114
Biospeciation of Potential Vanadium Drugs of Acetylacetonate in the Presence of Proteins 106
ESI-MS Study of the Interaction of Potential Oxidovanadium(IV) Drugs and Amavadin with Model Proteins 105
Rationalizing the Decavanadate(V) and Oxidovanadium(IV) Binding to G-Actin and the Competition with Decaniobate(V) and ATP 104
Binding of potential antitumor Casiopeínas® to small proteins 103
Effect of secondary interactions, steric hindrance and electric charge on the interaction of VIVO species with proteins 97
Unveiling VIVO2+ Binding Modes to Human Serum Albumins by an Integrated Spectroscopic–Computational Approach 90
A Series of Non-Oxido VIVComplexes of Dibasic ONS Donor Ligands: Solution Stability, Chemical Transformations, Protein Interactions, and Antiproliferative Activity 89
Binding of VIV O2+ , VIV OL, VIV OL2 and VV O2 L Moieties to Proteins: X-ray/Theoretical Characterization and Biological Implications 89
Protein‐Protein Stabilization in VIVO/8‐Hydroxyquinoline–Lysozyme Adducts 86
Polyoxovanadates with emerging biomedical activities 85
Mo(VI) Potential Metallodrugs: Explaining the Transport and Cytotoxicity by Chemical Transformations 85
Quantitative prediction of electronic absorption spectra of copper(II)–bioligand systems: Validation and applications 85
Solution chemistry of oxidovanadium(IV) complexes with two bis-kojic acid derivatives 80
New VIV, VIVO, VVO, and VVO2Systems: Exploring their Interconversion in Solution, Protein Interactions, and Cytotoxicity 79
Binding of vanadium ions and complexes to proteins and enzymes in aqueous solution 79
Through-Space Spin Coupling in a Silver(II) Porphyrin Dimer upon Stepwise Oxidations: AgII⋅⋅⋅AgII, AgII⋅⋅⋅AgIII, and AgIII⋅⋅⋅AgIII Metallophilic Interactions 78
Integrated experimental/computational approaches to characterize the systems formed by vanadium with proteins and enzymes 74
Interaction of VIVO–8-hydroxyquinoline species with RNase A: the effect of metal ligands in the protein adduct stabilization 73
Stepwise Oxidations in a Cofacial Copper(II) Porphyrin Dimer: Through-Space Spin-Coupling and Interplay between Metal and Radical Spins 70
Solution chemical properties and anticancer potential of 8-hydroxyquinoline hydrazones and their oxidovanadium(IV) complexes 69
Implications of Protein Interaction in the Speciation of Potential VIVO-Pyridinone Drugs 68
Ferromagnetic Coupling in Oxidovanadium(IV)-Porphyrin Radical Dimers 67
Experimental and Computational Studies on the Interaction of DNA with Hesperetin Schiff Base CuII Complexes 67
Multiple and Variable Binding of Pharmacologically Active Bis(maltolato)oxidovanadium(IV) to Lysozyme 59
The binding modes of VIVO2+ions in blood proteins and enzymes 59
Polyoxidovanadates' interactions with proteins: An overview 59
Promising anticancer agents based on 8-hydroxyquinoline hydrazone copper(II) complexes 58
New mixed ligand oxidovanadium(IV) complexes: Solution behavior, protein interaction and cytotoxicity 57
Interaction with CT-DNA and in vitro cytotoxicity of two new copper(II)-based potential drugs derived from octanoic hydrazide ligands 55
Stabilization and Binding of [V4O12]4− and Unprecedented [V20O54(NO3)]n− to Lysozyme upon Loss of Ligands and Oxidation of the Potential Drug VIVO(acetylacetonato)2 44
Totale 2.666
Categoria #
all - tutte 11.661
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.661


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202152 0 0 0 0 0 2 18 6 13 13 0 0
2021/202297 4 0 0 0 9 1 2 9 10 8 7 47
2022/2023332 32 42 16 57 20 48 0 42 64 1 8 2
2023/202491 18 7 4 8 20 4 0 3 4 0 10 13
2024/20251.027 4 8 45 25 23 57 102 201 316 154 66 26
2025/20261.051 57 298 287 217 162 30 0 0 0 0 0 0
Totale 2.666